GAO says FDA is too lax on DTC ads policing

Share this article:
The Government Accountability Office ripped the FDA for lax policing of DTC advertising, saying the agency was slow to act on dubious drug ads due to inconsistent standards and bureaucratic snafus. “We believe that regulatory letters should be issued more quickly,” said the GAO's report.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions